The objective of this study is to determine the long-term outcome of children with intractable epilepsy who have diffuse cortical hypometabolism on 2-deoxy-2-( 18 F)fluoro-D-glucose positron emission tomography (FDG-PET) scans. Seventeen children with intractable epilepsy showing bilateral, diffuse cortical hypometabolism on FDG-PET were followed up through telephone interview from 1 year 4 months to 11 years 4 months (mean: 5 years 7 months + 2 years 1 month) after their PET scans. One child succumbed to Sanfilippo disease at age 20 years. Only 2 children were seizure free. Fifty percent had walking difficulties, 56.25% were not toilet trained, all had speech difficulties, 43.75% had behavioral problems, 37.5% had poor eye contact, 75% had socialization difficulties, and 87.5% attended special schools. Three children were found to have genetic causes, including a 4-MB deletion of the mitochondrial genome, MECP2 duplication, and Lafora disease. In conclusion, the long-term outcome in this patient population is poor, and they tend to suffer from genetic/neurodegenerative diseases.
Children with epilepsy may respond well to pharmacological therapy; however, around 10% to 30% continue to have refractory seizures despite multiple anticonvulsant medications. [1] [2] [3] These children benefit from surgery if the seizures originate from a focal area. 4 Presurgical evaluation to localize the seizure onset zone includes interictal and ictal electroencephalogram (EEG), magnetic resonance imaging (MRI), neuropsychological evaluation, and functional neuroimaging using 2deoxy-2-( 18 F)fluoro-D-glucose positron emission tomography (FDG-PET) or single photon emission computed tomography (SPECT). 5, 6 MRI is the imaging modality of choice for evaluating patients with epilepsy (International League Against Epilepsy Commission on Neuroimaging). 7 However, when MRI fails to show a focal abnormality, FDG-PET or SPECT may provide the necessary localizing data. 6 When a hypometabolic focus is found on PET and there is strong correlation with the EEG, epilepsy surgery may be offered. 8 If multiple hypometabolic foci are shown on FDG-PET, the EEG often also indicates multifocal abnormalities and surgery is usually not an option, with some exceptions such as tuberous sclerosis. 9 It is not uncommon for the PET scan to reveal a diffuse or global pattern of glucose hypometabolism in children with intractable epilepsy. In such cases, an underlying structural lesion is unlikely; rather, an underlying genetic or metabolic process is suspected. These patients are almost never candidates for resective epilepsy surgery. The etiology and outcome in children showing a diffuse hypometabolism pattern are not known, but given the global involvement, it is likely to be poor but of heterogeneous etiologies. In the present study, we sought to determine the etiologies and long-term outcome of children with intractable epilepsy and a diffuse pattern of hypometabolism on PET imaging.
Materials and Methods Patients
The subjects of the present study were selected from 2166 patients with intractable epilepsy contained in the clinical FDG-PET database of the PET Center, Children's Hospital of Michigan, Detroit. These patients had been scanned at our center between 1993 and 2010. All of these patients had PET scans for localization of the seizure focus and were being considered for possible epilepsy surgery either at our center or other centers that lacked good access to PET. The patients showing a diffuse pattern of glucose hypometabolism are typically marked in our database as having potential genetic disease, degenerative disease, or inborn errors of metabolism. There were 169 patients who were classified into these categories. Upon further detailed visual evaluation of these 169 patients, 31 patients had an unambiguous pattern of severe bilateral diffuse cortical hypometabolism observed on FDG-PET scanning, and none were candidates for epilepsy surgery. These patients were then contacted through telephone interview to determine their natural outcome. Fourteen of these 31 patients were lost to follow-up, and 1 patient had died. The mean (standard deviation [SD]) age of the remaining 16 patients at the time of PET scanning was 9 (5.85) years with 9 males and 7 females. The mean (SD) age of these patients at follow-up was 15 (4.88) years. The range of follow-up was from 1 year 4 months to 11 years 4 months (mean, 5 years 7 months + 2 years 1 month). The details are provided in Table  1 . The Human Investigations Committee at Wayne State University granted permission for the retrieval and analysis of de-identified PET and outcome data that had been obtained clinically for these children.
PET Procedure
The tracer 18 F-FDG was produced in-house using a Siemens (Knoxville, Tennessee) RDS-11 cyclotron. 18 F-FDG PET studies were performed using a CTI/Siemens EXACT/HR whole-body PET scanner or a GE Discovery (Milwaukee, Wisconsin) STE PET-CT scanner. A 20minute static emission scan was acquired after a 30-min 18 F-FDG uptake period. Computed attenuation correction was used to correct the brain images for attenuation of 511-keV photons. All patients fasted for 4 hours before the 18 F-FDG injection (5.291 MBq/kg [0.143 mCi/kg]). During the 18 F-FDG uptake period, the children underwent continuous scalp EEG monitoring. During the scanning phase (but not during the uptake period), sedation was used, as necessary. All sedated patients were continually monitored by pediatric nurses with special training in the sedation of children for radiologic procedures. Heart rate, blood pressure, and pulse oximetry were also measured during the PET procedure.
Data Analysis
None of these 16 patients were found suitable for resective surgery on the basis of clinical, MRI, PET, and EEG data. PET scans were analyzed qualitatively through visual inspection, and the scans showing bilateral symmetric hypometabolism in 2 lobes of brain were designated as bilateral diffuse cortical hypometabolism. Review of the clinical charts was performed to identify any known etiologies. In addition, the EEG and MRI scans of all patients were again reviewed to ensure that there were indeed no focal abnormalities. The outcome data were obtained through telephone interview. All studies were performed in compliance with the regulations of the Wayne State University Human Investigations Committee.
Telephone Interview
Parents or guardians of the 17 patients were called and informed of the purpose of this study. Because 1 patient had died, the interview was conducted only for 16 patients. After consenting to participate, they completed a 30-to 80-minute telephone interview, which consisted of a questionnaire and a structured interview. The questionnaire consisted of items pertaining to the patient's current symptoms, medical care, diagnoses, academic functioning, school accommodations, developmental milestones, and behavioral problems. In addition, the Vineland Adaptive Behavior Scales, Second Edition, a measure that assesses adaptive skills in communication, socialization, daily living skills, and motor skills, was completed. This measure provides agenormalized standard scores for the 4 domains of functioning as well as an overall score of adaptive function. Higher scores indicate higher levels of functioning. This measure is widely used in research and has good reliability and validity. 10, 11 Only 15 patients completed the Vineland Adaptive Behavior testing.
Results
The MRI scans were normal in 12 children. Mild ventricular enlargement was seen in 3 children, and in 1 child, there was mild arrest of myelination in the peritrigonal white matter. The different patterns of diffuse hypometabolism found on PET are given in Table 1 and illustrated in Figure 1 . An underlying etiology for the intractable epilepsy was found in 4 children; 1 had MECP2 gene duplication, 1 had Lafora disease, 1 had a 4-MB deletion of his mitochondrial genome (Table 1) , and the 1 patient who died had Sanfilippo disease.
Developmental and Seizure Outcome
Of the 31 children with diffuse hypometabolism, 14 had their telephone number (available in our database) disconnected and were lost to follow-up. Of the remaining 17, 1 female died at age 20 years. She was diagnosed with Sanfilippo disease with recurrent thrombocytopenia. She was poorly responsive to external stimuli and had increased tone in all her extremities, resulting in her wheelchair-bound status.
Of the remaining 16 children, 2 were seizure free and 14 continued to have seizures (generalized tonic-clonic in 11 children) ( Table 1 ). The outcome of these patients in the different developmental subdomains is shown in Figure 2 . Nine children started walking at 11 to 15 months of age, 1 child at 18 months, 2 children at 4 years, and the remaining 4 were not yet walking. Of the 12 children who were ambulatory, 4 continued to have walking difficulties. One has poor balance, another cannot walk long distances, the third one needs assistance with a walker or gait belt, and the fourth one lost his motor skills at age 9 years. Only 7 children were toilet trained and were independent for their toileting needs. Eight children were nonverbal, 6 had limited speech with 3-to 4-word sentences and difficulty in finding words, and only 2 had near-normal speech with some mispronunciation. Behavioral difficulties were present in 7 children; 4 children flapped or shook their hands and put fingers in their mouth and 2 even bit their fingers, another 2 children repetitively clapped their hands, and 1 child keeps 40
Journal of Child Neurology 27(1) his hands fisted or up like a rabbit. Eye contact was normal in 10 children, and the remaining 6 children had poor eye contact. Eight children were socially isolated and were not playing with other children of their age group, 4 tried to play but lacked interactive social skills, whereas 4 children were normal in their social skills. Two children were not going to school at all because of their profound cognitive impairment, 2 were in a regular school but their performance was on the lower end of their grade level, and 12 children were attending some special school and were receiving occupational, speech, and physical therapy. Only 3 children had a family history of epilepsy. Three children had scoliosis, and 1 had pleuropulmonary blastoma. In general, the developmental outcome assessed in these children by the Vineland Adaptive Behavior Scales was very poor, and the details are given in Table 1 .
Discussion
A number of studies have shown that carefully selected patients with medically refractory epilepsy receive significant benefit from resection of the epileptic focus. In a randomized controlled trial of temporal lobectomy versus conventional drug therapy in adult patients with intractable temporal lobe epilepsy, 58% of patients assigned to surgery became seizure free, whereas only 8% of patients assigned to drug therapy were seizure free. 12 The best prognosis is observed in patients where the epileptogenic lesions could be localized. In a multivariate analysis of 193 epilepsy patients who underwent resective surgery, it was found that a focal lesion on MRI, correct localization by FDG-PET, and localized ictal onset on EEG were independent predictors of a good outcome. 13 The outcome of medically refractory epilepsy patients who are not candidates for epilepsy surgery is less well studied. In a retrospective review of 34 such patients with an average follow-up period of 4 years, only 21% achieved seizure remission. 14 Furthermore, a meta-analysis of studies comparing surgical and nonsurgical treatments in patients with intractable epilepsy found that only 12% of nonoperated patients were seizure free compared with 44% of surgical patients. 15 The outcome in children with intractable epilepsy after resective surgery is also promising. 16 In most centers performing epilepsy surgery on young children, the interictal and ictal 
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Journal of Child Neurology 27 (1) EEG, seizure semiology, and the MRI form the basis as to whether resective epilepsy surgery should be pursued. With increased access to PET, which is now available even in small community hospitals receiving daily delivery of 18 F-FDG, FDG-PET has assumed a greater role in the presurgical evaluation of adults and children with intractable epilepsy being considered for resective epilepsy surgery. This is particularly true when the MRI fails to show a focal abnormality or when presurgical localization data are discordant. At our center, FDG-PET scans play an important role in determining the epileptogenic zone in children with intractable epilepsy, including those with intractable infantile spasms. In the latter group, we have shown 4 different glucose metabolic patterns (focal, multifocal, bitemporal, and diffuse cortical hypometabolism). 17, 18 In the present study, we excluded those patients who had infantile spasms at the time of evaluation. However, similar patterns of abnormalities on FDG-PET are seen in patients without infantile spasms, and some of these have been described previously. For example, children with intractable epilepsy who showed bilateral medial prefrontal and temporal neocortical hypometabolism on FDG-PET often showed aggressive behavior. 19 This is in contrast to children with infantile spasms and bitemporal (neocortical and medial temporal lobe structures) cortical hypometabolism on FDG-PET, who showed severe developmental delay and low-functioning autism, usually without aggressive behavior. 17 Previous studies have shown the presence of a diffuse hypometabolic pattern in specific disease populations. This has been observed particularly in children with various metabolic and degenerative diseases of the nervous system. Pascual et al 20 performed FDG-PET scans on 14 patients with microcephaly, developmental delay, and seizures with known mutations of GLUT1 and found diffuse glucose hypometabolism throughout the cerebral cortex of all patients. The thalami were more hypometabolic than the cortex, and a more pronounced hypometabolism in medial temporal lobe structures was observed, which did not correlate with performance impairment or coexistence of epilepsy. Philippart et al 21 studied 7 patients with Spielmeyer-Vogt disease using FDG-PET and found an agerelated progression of glucose hypometabolism starting in the calcarine area and then spreading rostrally to involve the whole cortex. Calcarine hypometabolism was mild in the patients when they were young and increased with age. Chugani et al 22 found 4 major subtypes (unilateral focal, unilateral diffuse, bilateral diffuse, and normal) of glucose hypometabolism in a group of 15 patients with Lennox-Gastaut syndrome. Bilateral diffuse hypometabolism was the most common (8 of 15 patients) pattern found in these patients, as confirmed by Theodore et al. 23 De Volder et al 24 investigated regional brain glucose utilization by FDG-PET in 3 children with adenylosuccinase deficiency and found a marked hypometabolism in all cortical structures with the cerebellum, thalamus, and basal ganglia being spared. In 8 children with glutaric aciduria type, Al-Essa et al 25 found diffuse decreased glucose uptake in whole cerebral cortex in 7 and in thalami in 3 children. In a study by Molnar et al, 26 15 patients with mitochondrial diseases (mitochondrial myopathy [n ¼ 5]; mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes [n ¼ 4]; and chronic external ophthalmoplegia [n ¼ 6]) were investigated to determine their cerebral glucose metabolism. The authors found decreased FDG uptake in the majority of cerebral regions, and greatest glucose hypometabolism was demonstrated in the temporal region (temporal pole and medial temporal gyrus) and occipital poles. A recent case series of 2 children with Niemann-Pick disease type C by Kumar and Chugani 27 reported a distinctive pattern of severe hypometabolism on FDG-PET of the bilateral medial and inferior frontal cortex, as well as the bilateral parietal and temporal cortex. The intermediate parietal region was spared as compared with lateral and medial aspects.
We have suspected that the children included in this study may have an underlying neurogenetic, metabolic, or degenerative disorder accounting for their diffuse cortical hypometabolism pattern found on FDG-PET and for their seizure intractability. Figure 1 demonstrates that, even within this group, several more distinct patterns are seen, thus supporting the heterogeneity of this patient population. This pattern is likely to be a heterogeneous group with respect to etiology as well. Although 4 different genetic abnormalities could be detected in individual patients, we could not identify the etiology in the vast majority of patients. One of these patients suffered from Lafora disease caused by a mutation in the Laforin gene. The typical age of onset of progressive neurodegeneration in this disease is between 8 and 18 years of age, and the myoclonic seizures become intractable with age. The presence of additional modifying factors could be responsible for early age of onset in this patient. Mecp2 duplication syndrome is a recently described severe neurodevelopmental disorder inherited in an X-linked manner. 28 It is characterized by epilepsy, hypotonia, mental retardation, autistic behaviors, and ataxia. The third patient had a large 4-MB deletion of the mitochondrial genome, and the significance of this finding is unclear. The fourth patient died due to Sanfilippo disease at age 20 years.
Even though a diffuse hypometabolic pattern has been described in such specific populations, much less is known about their long-term outcomes. In general, a poor outcome can be expected in children with diffuse cortical glucose hypometabolism on PET, with some exceptions. This observation can be used to provide prognostic information for parents about their children. Surprisingly, a specific diagnosis had been reached in only 4 of the 17 patients who could be followed up. This emphasizes the need for better diagnostic tools in evaluating these children. With more access to genetic testing, it is likely that various other disorders will be uncovered in this population.
Limitations of This Study
There are a number of limitations in the present study. First, this is a retrospective study of patients scanned over 17 years, and many of the patients were not local patients who could be followed up easily but had been referred for a PET scan from many centers across the country and even from overseas. Therefore, a consistent pattern of evaluation of these children for underlying etiology is not likely to be the case. Second, we selected only cases that showed severe hypometabolism, the reason being that some anticonvulsant medications [29] [30] [31] [32] [33] as well as a recent seizure 34 may be associated with a mild cortical hypometabolism. Importantly, we excluded patients who were on the ketogenic diet at the time of PET because we have found the PET results to be uninterpretable in such cases.
